Zealand Pharma

Zealand Pharma is a Danish biotechnology company focused on developing next‑generation peptide therapeutics. The firm has advanced ten peptide drug candidates into clinical development, with two already approved and marketed, targeting obesity, chronic inflammation, and select rare diseases. Based in Søborg, Copenhagen, with an additional team in the United States, Zealand Pharma leverages strategic collaborations with industry leaders such as Roche and Boehringer Ingelheim to accelerate its leading obesity programs. The company’s mission is to deliver innovative peptide medicines that improve patient outcomes, offering a dynamic environment for professionals passionate about cutting‑edge biotech research and development.